CAMBRIDGE, England--(BUSINESS WIRE)--Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, and the MRC Laboratory of Molecular Biology (LMB), a world-class research laboratory dedicated to understanding important biological processes at the molecular level, today announced an exploratory research collaboration. The project aims to develop novel protein expression systems by leveraging rece
Full ArticleMogrify Enters Research Collaboration with the MRC Laboratory of Molecular Biology
Business Wire
0 shares
2 views